Back
 JBM  Vol.4 No.12 , December 2016
Trend of Respiratory Tract-Associated Streptococcus dysgalactiae Subsp. Equisimilius at General Japanese Hospital from 2013 to 2015
Abstract:
Streptococcus dysgalactiae subsp. equisimilius are pathogenic bacteria which cause various infectious diseases from acute pharyngitis to streptococcal toxic shock syndrome. Although Streptococcus dysgalactiae subsp. equisimilius infection has been increasing recently, the recent characteristic investigation of respiratory tract associated Streptococcus dysgalactiae subsp. equisimilius has not been performed in Japan. In this study, we analyzed the relationship between respiratory tract and norespiratory tract associated Streptococcus dysgalactiae subsp. equisimilius by investigating the recent clinical characteristics and antimicrobial susceptible patterns of 98Streptococcus dysgalactiae subsp. equisimilius isolated during 2013-2015 in Japan. There was significant difference of gender between respiratory tract and no respiratory tract associated Streptococcus dysgalactiae subsp. equisimilius. No Streptococcus dysgalactiae subsp. equisimilius from no respiratory tract were found under 18 years-old patients. The prevalence of clindamycin non susceptible Streptococcus dysgalactiae subsp. equisimilius isolates from respiratory tract was significant greater than those from non-respiratory tract. We also analyzed the relationship between respiratory tract associated Streptococcus dysgalactiae subsp. equisimilius and Streptococcus pyogenes in 2014.There was no significant difference of gender between Streptococcus dysgalactiae subsp. equisimilius and Streptococcus pyogenes. The numbers of Streptococcus pyogenes-infected patients were significantly greater than those of Streptococcus dysgalactiae subsp. equisimilius-infected patients in children from 1 to 18 years old. From antimicrobial resistance, we found that the numbers of clarithromycin resistant Streptococcus pyogenes were greater than those of clarithromycin resistant Streptococcus dysgalactiae subsp. equisimilius among respiratory tract isolation. Our results suggest that the clinical and antimicrobial susceptible patterns are useful for screening the respiratory tract associated Streptococcus dysgalactiae subsp. equisimilius infection.
Cite this paper: Minami, M. , Sakakibara, R. , Imura, T. , Watanabe, M. , Morita, H. , Kanemaki, N. and Ohta, M. (2016) Trend of Respiratory Tract-Associated Streptococcus dysgalactiae Subsp. Equisimilius at General Japanese Hospital from 2013 to 2015. Journal of Biosciences and Medicines, 4, 11-17. doi: 10.4236/jbm.2016.412002.
References

[1]   Facklam, R. (2002) What Happened to the Streptococci: Overview of Taxonomic and Nomenclature Changes. Clin Microb Rev, 15, 613-630. http://dx.doi.org/10.1128/CMR.15.4.613-630.2002

[2]   Brandt, C.M. and Spellerberg, B. (2009) Human Infections Due to Streptococcus dysgalactiae Subspecies Equisimilis. Clin Infect Dis., 49, 766-772. http://dx.doi.org/10.1086/605085

[3]   Vandamme, P., Pot, B., Falsen, E., Kersters, K. and Devriese, L.A. (1996) Taxaonomic Study of Lancefield Streptococcal Groups C, G, and L (Streptococcus dysgalactiae) and Proposal of S. dysgalactiae Subsp. Equisimilis Subsp. Nov. Int J Syst Bacteriol., 46, 774-781. http://dx.doi.org/10.1099/00207713-46-3-774

[4]   Hashikawa, S., Iinuma, Y., Furushita, M., Ohkura, T., Nada, T., Torii, K., Hasegawa, T. and Ohta, M. (2004) Characterization of Group C and G Streptococcal Strains That Cause Streptococcal Toxic Shock Syndrome. J Clin Mi-crobiol., 42, 186-192. http://dx.doi.org/10.1128/JCM.42.1.186-192.2004

[5]   Humar, D., Datta, V., Bast, D.J., Beall, B., De Azavedo, J.C.S. and Nizet, V. (2002) Streptolysin S and Necrotizing Infections Produced by Group G Streptococcus. The Lancet, 359, 124- 129. http://dx.doi.org/10.1016/S0140-6736(02)07371-3

[6]   Minami, M., Ichikawa, M., Matsui, H., Hata, N., Wakiyama, N., Matsumoto, M., Ohta, M. and Hasegawa, T. (2011) Prevalence of a Streptococcal Inhibitor of a Complement-Medi- ated Cell Lysis-Like Gene (sicG) in Streptococcus dysgalactiae Subsp. Equisimilis. Curr Microbiol., 62, 884-887. http://dx.doi.org/10.1007/s00284-010-9798-8

[7]   Ichikawa, M., Minami, M., Ohashi, M., Wakimoto, Y., Matsui, H. and Hasegawa, T. (2011) Clinical and Microbiological Analysis of Beta Hemolytic Streptococci during 2006-2010 at Nagoya University Hospital. Nagoya Med J., 51, 175-189.

[8]   Minami, M., Kuriyama, M., Ohshima, Y., Sakakibara, R., Imura, T., Morita, H., Kanemaki, N. and Ohta, M. (2015) Clinical Characteristics and Antimicrobial Susceptible Patterns of Streptococcus dysgalactiae Subsp. Equisimilius Isolates during 2009-2013 in Japan. Int. J. Curr. Microbiol. App. Sci., 4, 498-507.

[9]   Takahashi, T., Sunaoshi, K., Sunakawa, K., Fujishima, S., Watanabe, H. and Ubukata, K., Invasive Streptococcal Disease Working Group (2010) Clinical Aspects of Invasive Infections with Streptococcus dysgalactiae Ssp. Equisimilis in Japan: Differences with Respect to Streptococcus pyogenes and Streptococcus agalactiae Infections. Clin Microbiol Infect., 16, 1097-1103. http://dx.doi.org/10.1111/j.1469-0691.2009.03047.x

[10]   Takahashi, T., Asami, R., Tanabe, K., Hirono, Y., Nozawa, Y., Chiba, N. and Ubukata, K. (2010) Clinical Aspects of Invasive Infection with Streptococcus dysgalactiae Subsp. Equisimilisin Elderly Patients. J Infect Chemother., 16, 68-71. http://dx.doi.org/10.1007/s10156-009-0016-1

[11]   Clinical and Laboratory Standards Institute (2014) Performance Standards for Antimi-crobial Susceptibility Testing: 24st Information Supplement. Clinical and Laboratory Standards Institute M100-S24, Wayne.

[12]   Fuursted, K., Stegger, M., Hoffmann, S., Lambertsen, L., Andersen, P.S., Deleuran, M. and Thomsen, M.K. (2016) Description and Characterization of a Penicillin-Resistant Streptococcus dysgalactiae Subsp. Equisimilis Clone Isolated from Blood in Three Epidemiologically Linked Patients. J Antimicrob Chemother. http://dx.doi.org/10.1093/jac/dkw320

 
 
Top